RG

Redmile Group Portfolio holdings

AUM $1.36B
1-Year Est. Return 111.01%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+111.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.36B
AUM Growth
+$330M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
43
New
Increased
Reduced
Closed

Top Buys

1
+$63.4M
2
+$49.4M
3
+$14.3M
4
IMNM icon
Immunome
IMNM
+$12.2M
5
RAPT icon
RAPT Therapeutics
RAPT
+$10.4M

Top Sells

1
+$70.1M
2
+$46.2M
3
+$35.5M
4
COGT icon
Cogent Biosciences
COGT
+$21.7M
5
ETNB
89bio
ETNB
+$21.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLDX icon
26
Celldex Therapeutics
CLDX
$2B
$7.69M 0.57%
283,308
-43,700
LIVN icon
27
LivaNova
LIVN
$3.86B
$7.26M 0.53%
118,054
-808,745
IVVD icon
28
Invivyd
IVVD
$477M
$6.62M 0.49%
2,681,159
+395,839
XENE icon
29
Xenon Pharmaceuticals
XENE
$3.34B
$6M 0.44%
+133,882
RPTX
30
DELISTED
Repare Therapeutics
RPTX
$4.12M 0.3%
1,586,174
ALXO icon
31
ALX Oncology
ALXO
$277M
$3.69M 0.27%
3,264,718
-68,265
ORIC icon
32
Oric Pharmaceuticals
ORIC
$1.31B
$3.67M 0.27%
+448,110
PLRX icon
33
Pliant Therapeutics
PLRX
$79.9M
$1.97M 0.15%
1,616,228
+24,533
KLRS
34
Kalaris Therapeutics
KLRS
$196M
$700K 0.05%
82,955
AKRO
35
DELISTED
Akero Therapeutics
AKRO
– –
-747,818
ETNB
36
DELISTED
89bio
ETNB
– –
-1,473,136
FOLD icon
37
Amicus Therapeutics
FOLD
$4.51B
– –
-777,178
KROS icon
38
Keros Therapeutics
KROS
$432M
– –
-552,506
LVTX
39
DELISTED
LAVA Therapeutics
LVTX
– –
-2,074,372
PRME icon
40
Prime Medicine
PRME
$834M
– –
-87,118
VTYX icon
41
Ventyx Biosciences
VTYX
$1B
– –
-1,073,386
XERS icon
42
Xeris Biopharma Holdings
XERS
$1.02B
– –
-451,099
BOLD
43
Boundless Bio
BOLD
$26M
– –
-245,458
1
2